Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692) - PubMed (original) (raw)
Case Reports
. 2000 Oct:123 ( Pt 10):2130-40.
doi: 10.1093/brain/123.10.2130.
F Van Harskamp, I De Koning, M Cruts, C De Jonghe, S Kumar-Singh, A Tibben, H Tanghe, M F Niermeijer, A Hofman, J C Van Swieten, C Van Broeckhoven, C M Van Duijn
Affiliations
- PMID: 11004129
- DOI: 10.1093/brain/123.10.2130
Free article
Case Reports
Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692)
G Roks et al. Brain. 2000 Oct.
Free article
Abstract
Several mutations in the amyloid precursor protein (APP) gene may lead to either Alzheimer's disease or cerebral haemorrhage due to congophilic amyloid angiopathy (CAA). A single family is known in which both types of pathology are expressed because of a missense mutation at codon 692 of the APP gene (APP692). Here we describe the clinical and pathological expression of APP692 in eight patients with the mutation. Furthermore, 21 first-degree relatives with an a priori risk of 50% of being a carrier were tested for the APP692 mutation and studied for presymptomatic signs by neurological examination, neuropsychological testing and brain MRI. Patients with APP692 presented with haemorrhage, dementia or both. The dementia in patients with the APP692 mutation was compatible with Alzheimer's disease both clinically and neuropathologically. Of the 21 healthy relatives at 50% risk, five carried the APP692 mutation. The presymptomatic carriers showed a subtle, non-significant impairment of cognitive function compared with relatives without APP692. A significant increase in the number of periventricular and subcortical white matter lesions at young age was seen in presymptomatic carriers (mean age 26.4 years). The findings of this study suggest that a single (genetic) mechanism may underlie the pathology of Alzheimer's disease and CAA. These diseases are manifested subclinically by white matter pathology. Further insight into the relationship between CAA and Alzheimer's disease may provide clues about the aetiology of Alzheimer's disease.
Similar articles
- Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation.
Cras P, van Harskamp F, Hendriks L, Ceuterick C, van Duijn CM, Stefanko SZ, Hofman A, Kros JM, Van Broeckhoven C, Martin JJ. Cras P, et al. Acta Neuropathol. 1998 Sep;96(3):253-60. doi: 10.1007/s004010050892. Acta Neuropathol. 1998. PMID: 9754958 - Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.
Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, et al. Hendriks L, et al. Nat Genet. 1992 Jun;1(3):218-21. doi: 10.1038/ng0692-218. Nat Genet. 1992. PMID: 1303239 - Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.
Basun H, Bogdanovic N, Ingelsson M, Almkvist O, Näslund J, Axelman K, Bird TD, Nochlin D, Schellenberg GD, Wahlund LO, Lannfelt L. Basun H, et al. Arch Neurol. 2008 Apr;65(4):499-505. doi: 10.1001/archneur.65.4.499. Arch Neurol. 2008. PMID: 18413473 Free PMC article. - Cerebral amyloid angiopathy and dementia.
Tian J, Shi J, Mann DM. Tian J, et al. Panminerva Med. 2004 Dec;46(4):253-64. Panminerva Med. 2004. PMID: 15876981 Review. - Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ, Roos RA, Bots GT, Kamphorst W, Eikelenboom P, Van Nostrand WE. Rozemuller AJ, et al. Am J Pathol. 1993 May;142(5):1449-57. Am J Pathol. 1993. PMID: 7684195 Free PMC article. Review.
Cited by
- Clinical considerations in early-onset cerebral amyloid angiopathy.
Banerjee G, Collinge J, Fox NC, Lashley T, Mead S, Schott JM, Werring DJ, Ryan NS. Banerjee G, et al. Brain. 2023 Oct 3;146(10):3991-4014. doi: 10.1093/brain/awad193. Brain. 2023. PMID: 37280119 Free PMC article. Review. - Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C, Bertgen L, Koo EH, Brinkmalm G, Zetterberg H, Kins S, Eggert S. Schilling S, et al. Acta Neuropathol Commun. 2023 Jun 1;11(1):87. doi: 10.1186/s40478-023-01577-y. Acta Neuropathol Commun. 2023. PMID: 37259128 Free PMC article. - AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy.
Dent P, Booth L, Roberts JL, Poklepovic A, Martinez J, Cridebring D, Reiman EM. Dent P, et al. Aging (Albany NY). 2022 Oct 13;14(20):8221-8242. doi: 10.18632/aging.204337. Epub 2022 Oct 13. Aging (Albany NY). 2022. PMID: 36227739 Free PMC article. - Clinical Phenotype and Mutation Spectrum of Alzheimer's Disease with Causative Genetic Mutation in a Chinese Cohort.
Mao C, Li J, Dong L, Huang X, Lei D, Wang J, Chu S, Liu C, Peng B, Román GC, Cui L, Gao J. Mao C, et al. Curr Alzheimer Res. 2021;18(3):265-272. doi: 10.2174/1567205018666210608120339. Curr Alzheimer Res. 2021. PMID: 34102969 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical